The anticancer agent ellipticine on activation by cytochrome P450 forms covalent DNA adducts.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Biochemical Pharmacology

• Publication date

  2001-12-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0006-2952(01)00806-1PMID 11755121
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Synthesis and binding properties to DNA and to opioid receptors of enkephalin-ellipticinium conjugates.

  2009cited by this paper
• DNA-Drug Recognition and Effects on Topoisomerase 11-mediated Cytotoxicity A THREE-MODE BINDING MODEL FOR ELLIPTICINE DERIVATIVES*

  2001cited by this paper
• New Selective Inhibitors of Cytochrome P450 2B4 and an Activator of Cytochrome P450 3A6 in Rabbit Liver Microsomes

  2000cited by this paper
• New Selective Inhibitors of Cytochrome P450 2B4 and an Activator of Cytochrome P450 3A6 in Rabbit Liver Microsomes.

  2000cited by this paper
• Antitumour prodrug development using cytochrome P450 (CYP) mediated activation.

  1999cited by this paper
• Interactions between cytochrome P450 and cytochrome b5.

  1999cited by this paper
• Constitutive Activation of the Aromatic Hydrocarbon Receptor

  1998cited by this paper
• Preclinical evaluation of 9-chloro-2-methylellipticinium acetate alone and in combination with conventional anticancer drugs for the treatment of human brain tumor xenografts

  1998cited by this paper
• Presence and activity of cytochrome P450 isoforms in minipig liver microsomes. Comparison with human liver samples.

  1998cited by this paper
• Data of pre-clinical and early clinical trials of acriflavine and hydroxy-methyl-ellipticine reviewed, enriched by the experience of their use for 18 months to 6 years in combinations with other HIV1 virostatics.

  1998cited by this paper
• Differential expression of CYP1A1 and CYP1B1 in human breast epithelial cells and breast tumor cells.

  1998cited by this paper
• Association of cytochrome P450 1B1 (CYP1B1) polymorphism with steroid receptor status in breast cancer.

  1998cited by this paper
• Cytotoxic agents directed to peptide hormone receptors: defining the requirements for a successful drug.

  1998cited by this paper
• Cooperativity in oxidations catalyzed by cytochrome P450 3A4.

  1997cited by this paper
• Comparison of DNA adduct formation by aristolochic acids in various in vitro activation systems by 32P-post-labelling: evidence for reductive activation by peroxidases.

  1997cited by this paper
• Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors.

  1997cited by this paper
• Multienzyme-mediated stable and transient multidrug resistance and collateral sensitivity induced by xenobiotics

  1997cited by this paper
• Analysis of structural requirements for Ah receptor antagonist activity: ellipticines, flavones, and related compounds.

  1996cited by this paper
• Design, synthesis, and biological evaluation of ellipticine-estradiol conjugates.

  1996cited by this paper
• Detection of DNA adducts formed by aristolochic acid in renal tissue from patients with Chinese herbs nephropathy.

  1996cited by this paper
• Protonophoric Activity of Ellipticine and Isomers across the Energy-transducing Membrane of Mitochondria (*)

  1995cited by this paper
• Topoisomerase II Binds to Ellipticine in the Absence or Presence of DNA.

  1995cited by this paper
• Benzenediazonium ion derived from Sudan I forms an 8-(phenylazo)guanine adduct in DNA.

  1995cited by this paper
• Inhibition of p53 Protein Phosphorylation by 9‐Hydroxyellipticine: A Possible Anticancer Mechanism

  1995cited by this paper
• The immunohistochemical localization of drug‐metabolizing enzymes in prostate cancer

  1995cited by this paper
• High-field NMR and restrained molecular modeling studies on a DNA heteroduplex containing a modified apurinic abasic site in the form of covalently linked 9-aminoellipticine.

  1994cited by this paper
• Characterization of DNA adducts formed by aristolochic acids in the target organ (forestomach) of rats by 32P-postlabelling analysis using different chromatographic procedures.

  1994cited by this paper
• Anticancer specificity of some ellipticinium salts against human brain tumors in vitro.

  1994cited by this paper
• Expression of xenobiotic metabolizing enzymes in breast cancer

  1993cited by this paper
• Specificity of substrate and inhibitor probes for human cytochromes P450 1A1 and 1A2.

  1993cited by this paper
• Prophage induction by DNA topoisomerase II poisons and reactive-oxygen species: role of DNA breaks.

  1992cited by this paper
• Ellipticine increases the superhelical density of intracellular SV40 DNA by intercalation.

  1992cited by this paper
• Stimulation of topoisomerase II-mediated DNA cleavage by ellipticine derivatives: structure-activity relationship.

  1992cited by this paper
• Molecular analysis of mutations induced by the intercalating agent ellipticine at the hisd3052 allele of salmonella typhimurium TA98

  1992cited by this paper
• DNA-drug recognition and effects on topoisomerase II-mediated cytotoxicity. A three-mode binding model for ellipticine derivatives.

  1991cited by this paper
• Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes.

  1991cited by this paper
• Synthetic methods and reactions. 146. Olefins from crowded carbonyl compounds with tert-butyllithium (tert-butylmagnesium chloride)/thionyl chloride. Study of carbocationic reaction intermediates and rearrangement-cleavage under stable ion conditions using carbon-13 NMR spectroscopy

  1990cited by this paper
• Tests for the genotoxicity of m-AMSA, etoposide, teniposide and ellipticine in Neurospora crassa.

  1990cited by this paper
• Mechanism of formation and 32P-postlabeling of DNA adducts derived from peroxidative activation of carcinogenic non-aminoazo dye 1-phenylazo-2-hydroxynaphthalene (Sudan I).

  1990cited by this paper
• Attempts to target antitumor drugs toward opioid receptor-rich mouse tumor cells with enkephalin-ellipticinium conjugates.

  1989cited by this paper
• 32P-adduct assay: comparative recoveries of structurally diverse DNA adducts in the various enhancement procedures.

  1988cited by this paper
• Altered regulation of P-450IA1 expression in a multidrug-resistant MCF-7 human breast cancer cell line.

  1988cited by this paper
• DNA adduct formation of aristolochic acid I and II in vitro and in vivo.

  1988cited by this paper
• Mutagenicity of topoisomerase-active agents in bacteriophage T4.

  1988cited by this paper
• Mechanism of formation and structural characterization of DNA adducts derived from peroxidative activation of benzidine.

  1988cited by this paper
• Investigation of the bicinchoninic acid protein assay: identification of the groups responsible for color formation.

  1988cited by this paper
• Multimodal action of antitumor agents on DNA: the ellipticine series.

  1987cited by this paper
• Nuclease P1-mediated enhancement of sensitivity of 32P-postlabeling test for structurally diverse DNA adducts.

  1986cited by this paper
• Covalent binding of elliptinium acetate (NSC 264137) to nucleic acids of L1210 cells in culture.

  1986cited by this paper
• Peroxidase-catalyzed covalent binding of the antitumor drug N2-methyl-9-hydroxyellipticinium to DNA in vitro.

  1986cited by this paper
• Phase II study of elliptinium in advanced breast cancer.

  1985cited by this paper
• Dealkylation of pentoxyresorufin: a rapid and sensitive assay for measuring induction of cytochrome(s) P-450 by phenobarbital and other xenobiotics in the rat.

  1985cited by this paper
• Metabolism of nitrosamines by purified rabbit liver cytochrome P-450 isozymes.

  1985cited by this paper
• Ethoxy-, pentoxy- and benzyloxyphenoxazones and homologues: a series of substrates to distinguish between different induced cytochromes P-450.

  1985cited by this paper
• Mutagenic responses of thirteen anticancer drugs on mutation induction at multiple genetic loci and on sister chromatid exchanges in Chinese hamster ovary cells.

  1983cited by this paper
• Biochemical prophage induction assay: a rapid test for antitumor agents that interact with DNA.

  1983cited by this paper
• Mutagenicity and cytotoxicity of five antitumor ellipticines in mammalian cells and their structure-activity relationships in Salmonella.

  1983cited by this paper
• Comparison of the mutagenic responses of 12 anticancer drugs at the hypoxanthine-guanine phosphoribosyl transferase and adenosine kinase loci in Chinese hamster ovary cells.

  1983cited by this paper
• 32P-postlabeling analysis of non-radioactive aromatic carcinogen--DNA adducts.

  1982cited by this paper
• Purification to homogeneity and characterization of a form of cytochrome P-450 with high specificity for benzo[alpha]pyrene from beta-naphthoflavone-pretreated rat liver microsomes.

  1981cited by this paper
• Ellipticines and human liver microsomes: spectral interaction with cytochrome P-450 and hydroxylation. Inhibition of aryl hydrocarbon metabolism and mutagenicity.

  1981cited by this paper
• Influence of inducers of monooxygenases on cytotoxic efficiency of ellipticine on leukemia L1210 cells.

  1981cited by this paper
• NADPH-cytochrome c (P-450) reductase. Spectrophotometric and stopped flow kinetic studies on the formation of reduced flavoprotein intermediates.

  1979cited by this paper
• Properties of electrophoretically homogeneous phenobarbital-inducible and beta-naphthoflavone-inducible forms of liver microsomal cytochrome P-450.

  1976cited by this paper
• Synthesis of the tumour-inhibitory alkaloids, ellipticine, 9-methoxyellipticine, and related pyrido[4,3-b]carbazoles

  1967cited by this paper
• THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. I. EVIDENCE FOR ITS HEMOPROTEIN NATURE.

  1964cited by this paper

• Synthetic Approaches to Cytotoxic Quino[4,3-b]carbazole Frameworks Involving Thermal Electrocyclization of 2,3-Divinylindoles.

  2025cites this paper
• Copper-Catalyzed Intermolecular [2 + 2 + 2] Annulation of Diynes with Alkynes: Construction of Carbazoles.

  2025cites this paper
• Indole as a Versatile Building Block in Cycloaddition Reactions: Synthesis of Diverse Heterocyclic Frameworks

  2024cites this paper
• Formation of potentially toxic metabolites of drugs in reactions catalyzed by human drug-metabolizing enzymes

  2024cites this paper
• Synthesis of Cytotoxic Quino[4,3-b]carbazole Frameworks through an Intramolecular Diels-Alder Reaction.

  2023cites this paper
• Rh(I)-Catalyzed Cascade Carbonylative Cyclization of Propargyl α-Diazoindolacetates for Construction of Carbazoles.

  2023cites this paper
• Colistin Resistance and Management of Drug Resistant Infections

  2022cites this paper
• Lysosomal Exocytosis of Olivacine on the Way to Explain Drug Resistance in Cancer Cells

  2022cites this paper
• Exploration of Benzo[b]carbazole-6,11-diones as anticancer agents: Synthesis and studies of hTopoIIα inhibition and Apoptotic effects.

  2021cites this paper
• Paradoxical Pro-angiogenic Effect of Low-Dose Ellipticine Identified by In Silico Drug Repurposing

  2021cites this paper
• Integrative Bioinformatics Analysis Reveals Possible Targets and Mechanism of Ellipticine in Inhibiting Breast Cancer Stem Cells

  2021cites this paper
• Human Family 1–4 cytochrome P450 enzymes involved in the metabolic activation of xenobiotic and physiological chemicals: an update

  2021cites this paper
• Pharmacological blockage of the AHR-CYP1A1 axis: a call for in vivo evidence

  2021cites this paper
• Molecular modeling approaches to address drug-metabolizing enzymes (DMEs) mediated chemoresistance: a review

  2021cites this paper
• Growth inhibition of the harmful alga Prymnesium parvum by plant-derived products and identification of ellipticine as highly potent allelochemical

  2021cites this paper
• Bioactive Olivacine Derivatives—Potential Application in Cancer Therapy

  2021cites this paper
• Synthesis of chromene-fused heterocycles by the Intramolecular–Diels–Alder Reaction: An overview

  2021cites this paper
• FMS-like tyrosine kinase-3 (FLT3) inhibitors with better binding affinity and ADMET properties than sorafenib and gilteritinib against acute myeloid leukemia: in silico studies

  2021cites this paper
• Evaluation of Interactions of Selected Olivacine Derivatives with DNA and Topoisomerase II

  2021cites this paper
• Repurposing Ellipticine Hydrochloride to Combat Colistin-Resistant Extraintestinal Pathogenic E. coli (ExPEC)

  2020cites this paper
• Acid‐Promoted Hetero Annulation: An Expeditious Route to Construct Functionalized Pyrido‐ and Pyrimido[5′,4′:5,6]pyrido‐ Fused [ a ]Carbazoles

  2020cites this paper
• Aspidosperma species: A review of their chemistry and biological activities.

  2019cites this paper
• Application of hepatic cytochrome b5/P450 reductase null (HBRN) mice to study the role of cytochrome b5 in the cytochrome P450-mediated bioactivation of the anticancer drug ellipticine

  2019cites this paper
• Tyrosine kinase inhibitors vandetanib, lenvatinib and cabozantinib modulate oxidation of an anticancer agent ellipticine catalyzed by cytochromes P450 in vitro.

  2019cites this paper
• Neuroendocrinology Letters-Neuro Endocrinol Lett

  2019cites this paper
• Ellipticine, its Derivatives: Re-Evaluation of Clinical Suitability with the Aid of Drug Delivery Systems.

  2019cites this paper
• Tyrosine kinase inhibitors vandetanib , lenvatinib and cabozantinib 1 modulate oxidation of an anticancer agent ellipticine catalyzed by 2 cytochromes P 450 in vitro 3

  2019cites this paper
• Ellipticine-loaded apoferritin nanocarrier retains DNA adduct-based cytochrome P450-facilitated toxicity in neuroblastoma cells.

  2019cites this paper
• Application of hepatic cytochrome b 5 / P 450 reductase null ( HBRN ) mice to study the role of cytochrome b 5 in the cytochrome P 450-mediated bioactivation of the anticancer drug

  2019cites this paper
• Synthesis and Anticancer Activity of Oxadiazole Incorporated Ellipticine Derivatives

  2019cites this paper
• Applications of Friedel–Crafts reactions in total synthesis of natural products

  2018cites this paper
• Modulation of CYP1A1 metabolism: From adverse health effects to chemoprevention and therapeutic options.

  2018cites this paper
• Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling.

  2018cites this paper
• Synthesis and Biological Evaluation of Calothrixins B and their Deoxygenated Analogues.

  2018cites this paper
• Multilevel Approaches within the Local Pair Natural Orbital Framework.

  2017cites this paper
• ATM participates in the regulation of viability and cell cycle via ellipticine in bladder cancer

  2017cites this paper
• Cytochrome b5 plays a dual role in the reaction cycle of cytochrome P450 3A4 during oxidation of the anticancer drug ellipticine

  2017cites this paper
• hNET AS A TARGET FOR NEUROBLASTOMA NANOMEDICINE

  2017cites this paper
• Human Cytochrome P450 (CYP1A2)‐dsDNA Interaction in situ Evaluation Using a dsDNA‐electrochemical Biosensor

  2017cites this paper
• Synthesis and biological evaluation of oxadiazole incorporated ellipticine derivatives as anticancer agents

  2017cites this paper
• Investigation of cancer drug penetration in 2D and 3D tumor cell culture models

  2016cites this paper
• Effectiveness of human cytochrome P450 3A4 present in liposomal and microsomal nanoparticles in formation of covalent DNA adducts by ellipticine.

  2016cites this paper
• Engineering of a Nepetalactol-Producing Platform Strain of Saccharomyces cerevisiae for the Production of Plant Seco-Iridoids.

  2016cites this paper
• Active Site Mutations as a Suitable Tool Contributing to Explain a Mechanism of Aristolochic Acid I Nitroreduction by Cytochromes P450 1A1, 1A2 and 1B1

  2016cites this paper
• Induced expression of microsomal cytochrome b5 determined at mRNA and protein levels in rats exposed to ellipticine, benzo[a]pyrene, and 1-phenylazo-2-naphthol (Sudan I)

  2016cites this paper
• 3-(Dipropylamino)-5-hydroxybenzofuro[2,3-f]quinazolin-1(2H)-one (DPA-HBFQ-1) plays an inhibitory role on breast cancer cell growth and progression.

  2016cites this paper
• Heterologous expression of human cytochrome P450 2S1 in Escherichia coli and investigation of its role in metabolism of benzo[a]pyrene and ellipticine

  2016cites this paper
• In Silico Prediction of Cytochrome P450-Drug Interaction: QSARs for CYP3A4 and CYP2C9

  2016cites this paper
• Vacuolar-ATPase-mediated intracellular sequestration of ellipticine contributes to drug resistance in neuroblastoma cells.

  2015cites this paper
• Crystallographic study and biological evaluation of 1,4-dimethyl-N-alkylcarbazoles.

  2015cites this paper
• The Anticancer Drug Ellipticine Activated with Cytochrome 3 P450 Mediates DNA Damage that Determines its 4 Pharmacological Efficiencies: Studies with Knockout Mouse 5 Models and Pure Enzymes

  2015cites this paper
• The Anticancer Drug Ellipticine Activated with Cytochrome

  2015cites this paper
• Cytotoxicity of and DNA adduct formation by ellipticine and its micellar form in human leukemia cells in vitro.

  2015cites this paper
• A Pd-catalyzed direct entry to 11-substituted 6H-isoindolo[2,1-a]indol-6-one derivatives as potential anticancer agents

  2015cites this paper
• Internal Ribosome Entry Site-Based Bicistronic In Situ Reporter Assays for Discovery of Transcription-Targeted Lead Compounds.

  2015cites this paper
• Electrochemical study of ellipticine interaction with single and double stranded oligonucleotides.

  2014cites this paper
• Multicomponent synthesis of pyrido[2,3-a]carbazoles and cytotoxic activity

  2014cites this paper
• A new route to the synthesis of ellipticine quinone from isatin

  2014cites this paper
• Synthetic Access to Poly-Substituted 11H-Pyrido[3,2-a]carbazoles, a DNA-Intercalating Ellipticine Related Structure, and Their Antiproliferative Activity

  2014cites this paper
• Formation of DNA Adducts by Ellipticine and Its Micellar Form in Rats — A Comparative Study

  2014influential citation
• Loading of an anti-cancer drug onto graphene oxide and subsequent release to DNA/RNA: a direct optical detection.

  2014cites this paper
• An In silico Based Comparison of Drug Interactions in Wild and Mutant Human β-tubulin through Docking Studies

  2014cites this paper
• Effect of dihydromyricetin on benzo[a]pyrene activation in rats.

  2014cites this paper
• Preparation of pH-responsive polymer core-shell nanospheres for delivery of hydrophobic antineoplastic drug ellipticine.

  2014cites this paper
• The Anticancer Drug Ellipticine Activated with Cytochrome P450 Mediates DNA Damage Determining Its Pharmacological Efficiencies: Studies with Rats, Hepatic Cytochrome P450 Reductase Null (HRN™) Mice and Pure Enzymes

  2014cites this paper
• Synthesis of 4-propionyl-3-(4-substitutedphenylamino)- 2-(5-Nitropyridin-2-yl) isoxazol-5(2H)-ones and Their Rearrangements to Imidazo [1,2- a] pyridines and Indoles with Triethylamine (TEA)

  2014cites this paper
• Emerging Targets in the Bioactivity of Ellipticines and Derivatives

  2013cites this paper
• Synthesis of poly-(3-hydroxybutyrate-co-12 mol % 3-hydroxyvalerate) by Bacillus cereus FB11: its characterization and application as a drug carrier

  2013cites this paper
• Biomedical Importance of Indoles

  2013cites this paper
• The effect of benzo[a]pyrene on metabolic activation of anticancer drug ellipticine in mice.

  2013cites this paper
• Synthesis of N-methylcarbazoles from N-(2-iodoaryl)-N-methylanilines in the presence of potassium tert-butoxide and iron(II) bromide

  2013cites this paper
• downloaded from King’s Research Portal

  2013influential citation
• Old Drug, New Target

  2013cites this paper
• Ellipticine and benzo ( a ) pyrene increase their own metabolic activation and detoxication via modulation of expression and enzymatic activity of cytochromes P 450 1 A 1 and 1 A 2 : a comparative study

  2013influential citation
• Effects of ellipticine on ALDH1A1-expressing breast cancer stem cells—an in vitro and in silico study

  2013cites this paper
• Alkaloids derived from tryptophan: Terpenoid indole alkaloids

  2013cites this paper
• Study of DNA–ellipticine interaction by capillary electrophoresis with laser‐induced fluorescence detection

  2012cites this paper
• Floral meristem initiation and emergence in plants

  2012cites this paper
• Self-assembling peptide-based nanoparticles enhance anticancer effect of ellipticine in vitro and in vivo

  2012cites this paper
• Translational approaches targeting the p53 pathway for anti‐cancer therapy

  2012cites this paper
• Analysis of covalent ellipticine- and doxorubicin-derived adducts in DNA of neuroblastoma cells by the ³²P-postlabeling technique.

  2012cites this paper
• Contributions of human enzymes in carcinogen metabolism.

  2012cites this paper
• Anthracyclines and ellipticines as DNA-damaging anticancer drugs: recent advances.

  2012cites this paper
• The synergistic effects of DNA-targeted chemotherapeutics and histone deacetylase inhibitors as therapeutic strategies for cancer treatment.

  2012cites this paper
• Cytochrome b5 increases cytochrome P450 3A4-mediated activation of anticancer drug ellipticine to 13-hydroxyellipticine whose covalent binding to DNA is elevated by sulfotransferases and N,O-acetyltransferases.

  2012cites this paper
• Occurrence, biogenesis, and synthesis of biologically active carbazole alkaloids.

  2012cites this paper
• Crataegus monogyna buds and fruits phenolic extracts: Growth inhibitory activity on human tumor cell lines and chemical characterization by HPLC–DAD–ESI/MS

  2012cites this paper
• Synthesis of 2-amino-8-chloro-4-phenyl-5,11-dihydro-6H-pyrido[2,3-a]carbazole-3-carbonitrile: Structural and biological evaluation

  2012cites this paper
• Analysis of covalent ellipticine- and doxorubicin-derived adducts in DNA of neuroblastoma cells by the 32 P-postlabeling technique This work is dedicated to Professor Gustav Entlicher on the occasion of his 70 th birthday

  2012cites this paper
• Microwave assisted synthesis of indolo[2,3-b]dibenzo[b,g][1,8]naphthyridines

  2012cites this paper
• Ellipticine oxidation and DNA adduct formation in human hepatocytes is catalyzed by human cytochromes P450 and enhanced by cytochrome b5.

  2012cites this paper
• Carbazoles and Acridines

  2011cites this paper
• Ellipticine cytotoxicity to cancer cell lines — a comparative study

  2011cites this paper
• A novel structural derivative of natural alkaloid ellipticine, MDPSQ, induces necrosis in leukemic cells

  2011cites this paper
• L-Proline anchored multicomponent synthesis of novel pyrido[2,3-a]carbazoles; investigation of in vitro antimicrobial, antioxidant, cytotoxicity and structure activity relationship studies.

  2011cites this paper
• Cytochrome P450- and peroxidase-mediated oxidation of anticancer alkaloid ellipticine dictates its anti-tumor efficiency.

  2011influential citation
• Anticancer agent ellipticine combined with histone deacetylase inhibitors, valproic acid and trichostatin A, is an effective DNA damage strategy in human neuroblastoma.

  2011influential citation
• Cytochrome b(5) shifts oxidation of the anticancer drug ellipticine by cytochromes P450 1A1 and 1A2 from its detoxication to activation, thereby modulating its pharmacological efficacy.

  2011cites this paper
• Modifications to the Vilsmeier‐Haack formylation of 1,4‐dimethylcarbazole and its application to the synthesis of ellipticines

  2011cites this paper
• Impact of beta-naphthoflavone on genotoxicity of food-derived carcinogens.

  2011cites this paper